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INTRODUCTION
Comorbid diseases have emerged as the leading cause of 
mortality in gastric cancer patients, especially at the earlier stages 
[1,2]. Type 2 diabetes mellitus (T2DM) is one of the most common 
comorbidities in gastric cancer patients, with a prevalence of 
over 15% [3]. Patients with T2DM experienced various levels 
of glycemic control after undergoing curative gastrectomies as 
treatment for gastric cancers according to the gastrointestinal 
reconstruction methods [4,5]. Roux-en-Y gastrojejunostomy more 
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Purpose: Proximal intestinal bypass (PIB), such as Billroth II or Roux-en-Y gastrojejunostomy after curative distal 
gastrectomy for gastric cancer induces beneficial effects on glycemic control in patients with type 2 diabetes. We aimed to 
characterize the long-term evolution of pancreatic beta cells and insulin signaling in target tissue after a PIB procedure. 
Methods: Zucker diabetic fatty rats were randomly assigned to the PIB, sham-operated PIB pair-fed, and ad libitum fed 
groups. Oral glucose tolerance (GT) and plasma insulin levels were measured periodically at 16 weeks postoperatively. 
Histomorphometric analyses were performed to evaluate changes in islet architectures and intranuclear pancreatic 
duodenal homeobox 1 (PDX1) expression in beta cells. Insulin signaling changes in visceral adipocytes were measured by 
the phosphorylated Akt/Akt ratio. 
Results: Contrary to the progressively deteriorating GT and plasma insulin levels in sham-operated animals, these were 
preserved in PIB animals (P < 0.01) at 16 weeks postoperatively. The proportion of the islets having asteroid-like expanding 
projection was higher in PIB animals than in sham-operated animals (P < 0.01). PIB animals had 3-fold wider fractional 
area of beta cells (P < 0.01) and 3-fold higher proportion of beta-cell nuclear PDX1 expression (P < 0.01) than sham-
operated animals. PIB animals had significantly higher levels of Akt phosphorylation in the visceral adipocytes (P < 0.05). 
The PIB did not substantially affect weight and food intake postoperatively. 
Conclusion: The PIB preserved the plasma insulin levels and the wider beta-cell area over time and facilitated insulin 
signaling in the visceral fats. It could be considered as a possible reconstruction strategy for diabetic gastric cancer 
patients. 
[Ann Surg Treat Res 2021;100(4):218-227]
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effectively controls hyperglycemia in patients with gastric cancer 
and T2DM postoperatively, followed by loop gastrojejunostomy, 
whereas Billroth-I gastroduodenostomy merely affected glycemic 
control [4,6,7]. However, the suggested mechanisms by which 
loop gastrojejunostomy and Roux-en-Y gastrojejunostomy 
procedures affect the postoperative glycemic control are not 
clearly explained.
The metabolic surgical procedures performed to control 
hyperglycemia in obese patients with T2DM (i.e., Roux-en-Y 
gastric bypass, biliopancreatic diversion with or without duodenal 
switch, and one-anastomosis gastric bypass) commonly involve a 
proximal intestinal bypass (PIB) component [8,9]. We speculated 
that the PIB components involving both gastrectomies for gastric 
cancer and metabolic surgery might share a principal mechanism 
on glycemic control. Understanding the principal mechanism of 
improving glycemic control by loop gastrojejunostomy or Roux-
en-Y gastrojejunostomy would be crucial to further optimize 
gastrointestinal reconstruction after gastrectomy for the gastric 
cancer patient with T2DM.
The development of alterations in glucose homeostasis 
results from the gradual decline in beta-cell function occurring 
due to insulin resistance in the liver, muscle, and visceral 
fat [10]. Zucker diabetic fatty (ZDF; fa/fa) rat expresses severe 
insulin resistance at a young age and rapidly develops overt 
diabetic phenotype after a certain compensation period with 
the increased levels of responsive plasma insulin [11,12]. 
Failure of continuous compensation is mainly caused by an 
excess of beta-cell death in a setting in which cell replication 
fails to compensate for the rate of beta-cell loss with aging 
[13,14]. Certain types of antidiabetic pharmaceutical or surgical 
approaches may result in changes in the islet architecture in 
the T2DM animal models [15,16]. Inadequate knowledge on 
the PIB-type reconstruction in glucose homeostasis hampers 
interpretation of its primary role in pancreatic beta cells per 
se and leaves plenty of room for speculations rather than firm 
conclusions on its adoption to gastrectomy for the patients with 
gastric cancer and T2DM.
We hypothesized that the antidiabetic effect of the PIB 
procedure alone is implicated in primarily improving the 
pancreatic beta-cell function and simultaneously changing the 
peripheral insulin signaling. We aimed to characterize how 
PIB alone affects glucose tolerance (GT), pancreatic beta-cell 




Ten-week-old male ZDF rats (Charles River, Tokyo, Japan) 
were individually housed and maintained at 12:12-hour light/
dark cycle at constant ambient temperature and humidity (25°C 
and 50%–60%, respectively). Rats were fed Purina Lab diet 
#5008 (WF Fisher & Son, Bound Brook, NJ, USA) for the entire 
study duration. After 1 week of acclimatization, rats underwent 
oral glucose tolerance test (OGTT) to examine their diabetes 
status. Only ZDF rats with an overt diabetic phenotype (2-hour 
glucose level > 200 mg/dL) were included in the study. The 
Institutional Animal Care and Use Committee of College of 
Medicine, Hallym University approved the study protocol (No. 
HMC2012-1-0706-6). 
Study design
Twelve-week-old ZDF rats with overt diabetes were randomly 
assigned to the PIB, sham-operated PIB pair-fed (sham-PF), and 
sham-operated ad libitum fed (sham-AL) groups. The sham-
PF and -AL groups were included to control for caloric intake 
and weight changes. To investigate the weight-independent 
mechanism of the surgical interventions, the sham-PF group 
was included at 1 week after PIB. The 3 groups were followed 
up at 16 weeks postoperatively. The pancreas was obtained 
from the subjects of each group at terminal tissue harvest. 
Additionally, to investigate the natural course of the changes 
in beta-cell function in ZDF rats, plasma insulin levels were 
measured in a separate set of unoperated control ZDF rats and 
normal Sprague-Dawley rats every corresponding time point 
from ages 6 to 28 weeks.
Surgical procedures
For the surgical procedure, rats were fasted overnight (12 
hours) and anesthetized with 2% isoflurane and oxygen. The 
PIB procedure was designed to adhere to the concept of the 
stand-alone stomach-sparing bypass that only excludes the 
duodenum and proximal jejunum, such as that in human 
Roux-en-Y reconstruction, which was performed as previously 
described [17]. Briefly, the duodenum was divided just distal to 
the pylorus, and the distal segment was closed with number 5-0 
Prolene sutures (Ethicon, Piscataway, NJ, USA). The jejunum was 
divided 5 cm distal to the ligament of Treitz, and the distal limb 
was anastomosed using number 5-0 Vicryl sutures (Ethicon) to 
the proximal segment of the duodenum. The continuity of the 
biliopancreatic limb was restored by end-to-side anastomosis 
with the alimentary limb 10 cm distal to the gastrojejunostomy 
site in a Roux-en-Y manner. The abdominal cavity was closed 
in layers. The laparotomy without experimental bowel 
manipulation was performed in the shame-operated ZDF rats. 
The operation time was prolonged to produce a similar degree 
of anesthetic and surgical stresses as in the respective PIB 
group.
Postoperative care
Subcutaneous injections of buprenorphine (0.01 mg/kg body 
weight [BW] twice daily for 2 days) were administered to all 
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postoperative rats. Antibiotics were not administered to rats 
after surgery.
Outcome measures
BW and food intake (FI) were measured daily between 9:00 
am and 10:00 am throughout the study period. The sham-PF 
rats were given access to the exact amount of food eaten by the 
surgical rats on the previous day.
Oral glucose tolerance test
After an overnight fast (12 hours), rats received an oral load 
of glucose (2 g/kg BW) via oral gavage. Blood samples were 
collected from the rats’ tail vein before (t = 0 minute) and 15, 
30, 60, 120, and 180 minutes after glucose administration using 
Microvette CB 300 K2E tubes (Sarstedt, Nuernbrecht, Germany) 
containing dipeptidyl peptidase IV inhibitor (Millipore, 
MA, USA). Blood glucose levels were determined using an 
automated blood glucose reader (YSI2700 SELECT Biochemistry 
Analyzer, Biocompare, San Francisco, CA, USA). The tubes were 
immediately placed on ice, and within 1 hour, the plasma was 
prepared by centrifugation (2,795 ×g at 4°C) using an Eppendorf 
bench top centrifuge and stored at –80°C until assay. GT was 
calculated as area under the curve (AUC) with t0 starting and 
t180 ending points for each experiment. Results are expressed 
as glucose excursion (GE) curves and delta AUC of OGTT. OGTT 
was performed preoperatively and repeated at 2, 4, 8, and 16 
weeks postoperatively.
H&E, anti-insulin immunohistochemistry, anti-
pancreatic duodenal homeobox-1, and Masson’s 
trichrome staining
The bodies of the pancreas were obtained at 16 weeks 
postoperatively from the subjects of each group at terminal 
tissue harvest in the first set of studies. The pancreas 
was removed and fixed by immersion in 10% neutral 
buffered formalin 24 hours before standard processing and 
embedding in paraffin wax. The pancreas was embedded to 
demonstrate the head/tail orientation and maximize the area 
of tissue sections, which were stained with H&E followed 
by subsequent histopathological examination. Anti-insulin 
immunohistochemistry (IHC) was performed to identify 
beta cells containing cytoplasmic insulin granules using a 
mouse anti-insulin monoclonal primary antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA) and a biotinylated mouse 
secondary antibody (Vector Labs, Burlingame, CA, USA) with 
the strep-ABC/HRP kit (Vector Labs). Insulin immunopositivity 
was visualized as brown staining of the beta-cell cytoplasm. To 
evaluate the pancreatic duodenal homeobox 1 (PDX1) activity 
in the beta-cell nucleus, the sections were immunostained 
for immunoperoxidase using the ABC kit (Vector Labs) or 
immunofluorescence. Histochemical demonstration of the 
infiltration of fibrous tissue in the islets was performed by 
Masson’s trichrome staining.
Histomorphometric analysis of the islets
To evaluate the time-course changes in islet morphology, the 
pancreas was harvested from ZDF control rats (12- and 20-week-
old ZDF rats; n = 6 in each age group). In the H&E-stained 
sections, the islets were defined as clusters of ≥8 beta cells 
associated with other morphologically identifiable endocrine 
cells, and all visualized islets were counted in every section. 
The proportion of the number of islets showing expanding 
features (asteroid shape) to the total islets was calculated in 
each section from the control ZDF rats and every group. Two 
pathologists counted the total number of islets from each section 
and the number of islets with expanding features in each 
section. The proportions of expanding islets in every section 
generated by each pathologist were averaged (<5% variability 
in the proportions found between the 2 pathologists). The 
fractional area of beta cells per unit section was measured. For 
each pancreas, 2 sections separated by 250 μm were analyzed. 
Islet images were captured using a MIRAX SCAN (Carl Zeiss, 
Thornwood, NY, USA) with a 200× objective lens. Light 
source intensity and image hue, brightness, and saturation 
were standardized in every section. The beta-cell area was 
automatically determined using a preset positive pixel count 
algorithm with MetaMorph software ver. 7.7.4.0 (Molecular 
Devices, Inc., Sunnyvale, CA, USA). The fractional area of beta 
cell was expressed by a ratio of the insulin-positive pixel counts 
to the total pixel counts corresponding to the total pancreatic 
area in a section. The proportions of the number of anti-insulin 
positive beta cells per total number of the cells in the islet and 
the proportion of nuclear PDX1 positive beta cells per total 
number of the anti-insulin positive beta cells in the islet were 
also calculated. In the Masson’s trichrome-stained sections, 
the degree of fibrosis of the islet in each group was blindly 
assessed by 2 pathologists using a semi-quantifying fibrosis 
scoring system (0, none; 1, mild; 2, moderate; 3, marked; and 4, 
complete effacement). The fibrosis scores in every section that 
were estimated by each observer were averaged.
Western blot for Akt phosphorylation in visceral fat
Viscera l  fat  t i ssues were har vested at  16 weeks 
postoperatively from ZDF rats in the PIB, sham-PF, and sham-AL 
groups. Tissues were homogenized in 1 mL of NP40-containing 
lysis buffer (150-mM NaCl, 50-mM Tris pH 8.0; 5-mM EDTA, 1% 
NP40) containing protease and phosphatase inhibitors (2-μg/mL 
leupeptin, 2-μg/mL aprotinin, 1-mM sodium orthovanadate, 10-
mM sodium fluoride, and 1-mM phenylmethylsulfonyl fluoride). 
Tissue extract was cleared by centrifugation (12,000 ×g for 
15 minutes). Protein samples were boiled with 4× lithium 
dodecyl sulfate Nupage sample buffer from Invitrogen (NP0007, 
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Carlsbad, CA, USA) for 2 minutes before loading. Electrophoresis 
was performed at 80 mA using MES-SDS running buffer from 
Invitrogen. Transfer was performed at a temperature of 4°C at 
100 V for 90 minutes. Polyvinylidene difluoride membranes 
were blocked in 5% milk-Tris-buffered saline-T. Anti-pAkt, anti-
Akt, and anti-actin antibodies were probed overnight at 4°C. 
The phosphorylated Akt/Akt ratio of each group was expressed 
by the percent of the relative intensity of phosphorylated Akt 
compared to Akt intensity. 
Statistical analyses
Data were analyzed using 1-way analyses of variance 
(ANOVAs). Significant differences between treatment groups 
were followed up with post hoc Bonferroni multiple comparison 
tests. Sequential variations were analyzed by 2-way repeated 
measures of ANOVA with Tukey post hoc differentiation, where 
appropriate. Data are expressed as mean ± standard error 
of the mean. Non-parametric tests (e.g., the Kruskal-Wallis 
test) were performed if appropriate. A P-value of <0.05 was 
considered statistically significant. Statistical analyses were 
performed using Graphpad Prism ver. 9.0 (San Diego, CA, USA).
RESULTS
Effect of proximal intestinal bypass on changes 
of food intake, body weight, glucose excursion, 
glucose tolerance, and plasma insulin levels
FI was transiently lower in the PIB group than in the sham-
AL group at 2 weeks after surgery (P < 0.05). However, there was 
no significant difference in average daily FI during the study 
period between the PIB and sham-AL groups (Fig. 1A). BW in 
the PIB and sham-PF animals was transiently lower than that 
of the sham-AL animals at 2 weeks after surgery (P < 0.05). 
Subsequently, all 3 groups did not show any difference in weight 
gain at 16 weeks postoperatively (Fig. 1B). The GE curve and 
delta AUC-OGTT were significantly lower in the PIB group than 
in sham-operated rats at 2 weeks postoperatively (both P < 0.01) 
(Fig. 2A, B). PIB animals showed significantly lower delta AUC-
OGTT than sham-operated animals at 16 weeks after surgery 
(P < 0.01) (Fig. 2B). Fasting and oral glucose-challenged plasma 
insulin levels in the PIB animals were significantly higher than 
those of the sham-operated animals at 16 weeks postoperatively 
(P < 0.01) (Fig. 2C, D).
Characteristics of the development and progression 
of diabetes in ZDF rats
Fasting plasma glucose levels in ZDF rats significantly 
increased at 8 weeks of age and then after (P < 0.01, Fig. 3A). 
Plasma insulin levels were significantly increased until 8 
weeks of age (5.8 ± 1.7 ng/mL vs. 9.1 ± 3.7 ng/mL, P < 0.01) 
and significantly decreased until 28 weeks of age (1.0 ± 0.2, P 
< 0.01) (Fig. 3B). The patterns of plasma insulin decline in the 
unoperated control ZDF rats were exactly the same as that of 
the sham-operated animals (Fig 2C, D).
Effect of PIB procedure on the morphological 
modification of the islets
Sixteen weeks after surgery, the islets of the PIB animals 
aged 28 weeks showed asteroid-like expansions similar to that 
observed in 12-week-old unoperated control ZDF rats (Fig. 4A, 
D), whereas the islet of the sham-operated animals and 28-week-
old unoperated control ZDF did not show such feature (P = 0.98) 
















































































Fig. 1. Postoperative changes in food intake (FI) and body weight (BW). The transient difference in FI and BW between PIB 
and sham-AL rats weakened over time. There were no significant differences in the average daily FI and weight gain between 
the PIB and sham-operated rats at 16 weeks postoperatively. PIB, proximal intestinal bypass (n = 16); sham-PF, sham-operated 
paired-fed (n =10); sham-AL, sham-operated ad libitum fed (n = 10). ∆FI = FI (postoperative – preoperative)/preoperative ×100; 
daily FI = average daily FI during the 16-week study period; BW gain = BW (16 weeks – 1 week before surgery)/1 week before 
surgery × 100. Data are shown as mean ± standard error of the mean. *P < 0.05 (by analysis of variance test).
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Fig. 3. Characterizing the development of overt diabetes and its progression in Zucker diabetic fatty (ZDF) rats (n = 6). Overt 
hyperglycemia is accompanied by decreased plasma insulin levels, confirming the decompensation of beta-cell function and 
progressive nature of insulin deficiency in ZDF rats. SD, Sprague-Dawley rats (n = 6). Data are expressed as mean ± standard 



































































































Fig. 2. Effect of the PIB procedure on glucose excursion (GE), glucose tolerance (GT), and the postoperative plasma insulin levels. 
Only the PIB rats had improvement in GE (A) and GT (B) at 2 weeks postoperatively. The PIB procedure inhibited progressive 
deterioration of GT, despite the fact that the PIB and sham-PF and -AL animals had similar FI and weight gain. The PIB procedure 
prevented the gradual decline of fasting (C) and oral glucose-challenged (D) plasma insulin levels of Zucker diabetic fatty rats 
at 16 weeks postoperatively. PIB, proximal intestinal bypass (n = 16); sham-PF, sham-operated paired-fed (n = 10); sham-AL, 
sham-operated ad libitum fed (n = 10); AUC-OGTT, area under the curve of oral glucose tolerance test. ∆ = (postoperative – 
preoperative)/preoperative × 100. Data are expressed as mean ± standard error of the mean. *P < 0.01 (by 2-way repeated 
measures of analysis of variance with Tukey’s post hoc test).
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(Fig. 4B, C, E). The proportion of expanding islets in the PIB 
animals was significantly higher than that of the sham-operated 
animals (P < 0.01) (Fig. 4F). 
Effect of PIB procedure on the pancreatic beta-
cell area, beta-cell maturation, and fibrous tissue 
infiltration in the islets
The areas of asteroid-like expansions of the islets in PIB 
(Fig. 5A) rats were positively stained by anti-insulin IHC in the 
matched pancreatic sections (i.e., consistent with the area of 
islet expansion shown by H&E staining) (Fig. 4A). Fractional area 
of anti-insulin IHC-positive beta cells per microscopic field unit 
was significantly higher in PIB rats than in sham-PF and -AL rats 
(0.029 ± 0.007, 0.008 ± 0.003, and 0.007 ± 0.002, respectively; P 
< 0.01) (Fig. 5D–G). The proportion of the nuclear PDX1-positive 
beta cells was significantly higher in PIB animals than in sham-
operated animals (0.26 ± 0.03, 0.08 ± 0.04, and 0.09 ± 0.01, 
respectively; P < 0.01) (Fig. 5H–K). Fibrosis scores in PIB animals 
tended to be lower than those of the sham-AL animals (1.8 ± 0.4, 
1.7 ± 0.5, and 2.4 ± 0.5, respectively; P = 0.07) (Fig. 5L–O).
Effect of PIB procedure on insulin signaling in 
visceral fat tissues
The phosphorylated Akt/Akt ratio was significantly higher in 
PIB rats than in sham-operated rats (P < 0.05) (Fig. 6).
DISCUSSION
Previous studies have shown that the patient who underwent 
gastrectomy for gastric cancer with gastrojejunostomy or Roux-
en-Y reconstruction resulting in the exclusion of duodenum 
and proximal jejunum from food passage enjoyed the anti-
hyperglycemic effect postoperatively [4-7]. They emphasized the 
intrinsic role of bypassed proximal duodenum and jejunum. 
They often simultaneously claimed the weight loss effect as one 

















































Fig. 4. Effect of the PIB procedure on the preservation of the morphological modification of the islets in Zucker diabetic fatty 
(ZDF) rats. The majority of islets in the PIB rats aged 28 weeks (A) showed asteroid-like projections (arrow) similar to those 
seen in 12-week-old control ZDF rats (D) (F). In contrast, these projections of the islets were not frequently seen in the sham-
operated animals at 16 weeks postoperatively and 28-week-old control ZDF rats (B, C, E) (F). Expanding islets = number of 
islets showing asteroid-like expansions/total number of islets in unit pancreas (H&E, ×200). PIB, proximal intestinal bypass (n 
= 16); sham-PF, sham-operated paired-fed (n = 10); sham-AL, sham-operated ad libitum fed (n = 10). *P < 0.01 (by analysis of 
variance test).
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the pylorus to investigate the sole effect of PIB procedure 
without any dumping-like symptoms that may reduce the FI 
and induce a concomitant weight loss in this study. Notably, 
despite the absence of difference in FI and weight gain profile, 
the PIB procedure solely ameliorated GT and even successfully 
maintained better glycemic control over time. We confirmed 
that the PIB procedure alone could confer GT improvement by 
a mechanism beyond caloric restriction and weight loss in ZDF 
rats.
In contrast to the progressively aggravated GT in both 
the sham-operated groups, which were confirmed in these 
genetically programmed severe diabetic rats, the PIB procedure 
preserved distinguishable courses in T2DM progression in the 
long-term follow-up period. The exclusive role of the stand-
alone PIB procedure may be not only a key to treat T2DM but 
also an interesting area of research in the pathophysiology 
of diabetes. However, the paucity of data showing long-term 
consistent outcomes on beta-cell function after duodenal 
or proximal jejunal bypass surgery leads to making a firm 
conclusion difficult yet [1,19,20]. The reasons are partly because 
of the fact that most of the previous studies measured the 




































































































Fig. 5. Changes in the pancreatic beta-cell area, the beta-cell maturation, and the fibrous tissue infiltration in the islets after 
the PIB procedure in Zucker diabetic fatty rats. In the PIB rats (A), anti-insulin immunohistochemistry (IHC)-positive cells were 
present beyond the boundaries of typical discrete islets in the majority of islets, which was not observed in the sham-PF (B) and 
sham-AL (C) rats (anti-insulin IHC staining, pancreas, ×200). The PIB rats (D) had preservation of a wider fractional area of the 
anti-insulin IHC-positive beta-cell area (fluorescence in green) in the pancreatic islets than the sham-PF (E) and sham-AL (F) rats 
(G) (anti-insulin IHC staining, pancreas, ×200). The PIB rats (H) had higher anti-pancreatic duodenal homeobox 1 (PDX1) IHC-
positivity rate (fluorescence in white) in the beta-cell (in red) of the nucleus (in blue) than the sham-PF (I) and sham-AL (J) rats 
(K) (anti-intranuclear PDX1 IHC stain, pancreas, ×200). The PIB rats (L) showed a similar marginal area of fibrosis infiltration 
to the sham-PF (M), but that was lower in the PIB rats than in the sham-AL (N) rats (O) (P = 0.07) (Masson’s trichrome staining, 
pancreas, ×200). PIB, proximal intestinal bypass (n = 16); sham-PF, sham-operated paired-fed (n = 10); sham-AL, sham-
operated ad libitum fed (n = 10). *P < 0.01 (by analysis of variance test).
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[19,20]. We investigated the time-course variations in plasma 
insulin concentrations to determine the sustained effect of PIB 
reconstruction on the pancreatic beta-cell deterioration during 
the development and progression of T2DM. Interestingly, 
the PIB procedure eventually preserved the plasma insulin 
levels, which are primarily responsible for GT throughout the 
postoperative period. Given the data on greater plasma insulin 
concentrations coinciding with better GT throughout the 
study period, we suggested that the long-term effect of the PIB 
procedure on GT is partly attributable to the preservation of the 
plasma insulin levels in ZDF rats.
In the PIB animals, over 2/3 of the islets expressed the 
projections that were 2-fold more frequent compared to the 2 
groups of sham-operated animals. The higher plasma insulin 
levels may be attributable to a higher proportion of these 
asteroid-like islet expansions after the PIB procedure. The 3-fold 
wider fractional area of beta cells seemed to be attributable to 
these striking features of projections of the islets beyond the 
boundaries and the lesser degenerative changes in islets. In 
this respect, we focused on the morphological modifications 
of the islets that might have occurred during the development 
of diabetes in ZDF rats. Earlier reports demonstrated that 
duodenojejunal bypass surgery showed hypertrophic islets 
in 12-week-old ZDF rats [21]. A recent report showed that 
hypertrophied expanding islets compressed the adjacent 
exocrine tissues as early as 6 weeks of age in ZDF rats [22]. 
Farilla et al. [23] reported these budding appearances in a 
12-week-old ZDF rat. Notably, incretin (glucagon like peptide-1)-
treated 12-week-old ZDF rats presented enhanced irregularity 
of the margins of the islets and extensive branching out of 
cells from the periphery of the islets with 3.4-fold higher 
plasma insulin levels compared to age-matched controls. We 
also demonstrated that the PIB procedure gave rise to a 3-fold 
higher PDX1 activity in the beta-cell nucleus. PDX1 plays a 
crucial role in pancreas development, beta-cell differentiation, 
and maintaining mature beta-cell function [24]. Interestingly, 
both groups of the sham-operated animals lost projections 
of the islets by the same degrees as in the 28-week-old ZDF 
controls. The mechanism of facilitated beta-cell maturation 
and prohibited degenerative changes of the islet by the PIB 
procedure in this genetically programmed progressive T2DM 
rats needs to be further elucidated in terms of enteroendocrine 
hormonal milieu, especially the incretin-based mechanisms. 
On the other hand, the PIB procedure alone facilitated insulin 
signaling in visceral adipocytes. Akt, also known as protein 
kinase B, is a protein kinase that plays a pivotal role in various 
cellular processes, including cell proliferation, migration, 
apoptosis, and glucose metabolism [25]. Dysregulation of 
Akt signaling leads to the development of obesity and T2DM 
due to defective glucose transport and glycogen synthesis 
[26]. Considering the induction of Akt activation, we suggest 
that the PIB procedure can ameliorate glucose homeostasis 
partly through its substantial role not only in preserving the 
pancreatic beta-cell viability but also in upregulating the insulin 
signaling pathway in peripheral tissues [27]. 
The well-known metabolic surgeries result in reduced 
gastric volume, followed by gastrointestinal anatomical 
reconstruction. Likewise, gastrectomy and concomitant small 
bowel reconstruction also elicit beneficial effects on glucose 
homeostasis in diabetic gastric cancer patients postoperatively 
[4,18,28]. In our previous study, postoperative favorable changes 
in glucose metabolism are greater after loop gastrojejunostomy 
than after gastroduodenostomy following gastrectomy for 
gastric cancer [7]. Interestingly, each gastrojejunostomy and 
conventional Roux-en-Y reconstruction could provide a similar 
beneficial effect on GT, whereas the gastroduodenostomy did 
not [4,7,28]. On the other hand, Lee et al. [29] reported that 
long-limb bypass is essential for improving long-term glycemic 
control. A multicenter study also demonstrated the favorable 
glycemic control after the long-limb (>80 cm of each alimentary 
and biliopancreatic limb) Roux-en-Y bypass reconstruction over 
conventional loop gastrojejunostomy after gastrectomy despite 
no difference in body mass index reduction [5]. However, there 
was a possibility that the long-limb reconstruction might be 






























































Fig. 6. The effect of the proximal intestinal bypass (PIB) 
procedure on Akt phosphorylation in visceral fat tissues 
in Zucker diabetic fatty (ZDF) and Sprague-Dawley (SD) 
rats. The PIB animals (n = 16) showed an enhanced insulin 
signaling in the visceral adipocyte than the sham-operated 
paired-fed (PF, n = 10) and sham-operated ad libitum fed 
rats (AL, n = 10). Akt phosphorylation in visceral fat was 
evaluated by Western blotting. Western blots were probed 
with anti-P-Akt and anti-Akt antibodies. The results are 
expressed as the percentage of the P-Akt/Akt ratio. Data are 
expressed as means ± standard error of the mean. *P < 0.01 
(by analysis of variance test). P-Akt, phosphorylated Akt.
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acting as a 2-faced Janus, showing favorable glycemic control and 
possible detrimental nutritional deficiency [1], although Park et 
al. [30] demonstrated no significant differences in nutritional 
parameters between long-limb and conventional Roux-en-Y 
reconstructions. Notably, even though we established the Roux-
en-Y type PIB procedure consisted of a conventional limb length, 
which was composed of about 15% of the total small intestine 
of the rats, we successfully demonstrated the beneficial effect 
of the PIB on GT and the substantial suggestive mechanism by 
which it works. In this respect, we carefully propose adopting 
the salutary effects of PIB reconstruction into the patients with 
T2DM undergoing gastrectomy for gastric cancer based on the 
successfully characterized substantial effects of PIB procedure 
on GT in ZDF rats. Further study is warranted to determine the 
optimal length of the bypassed limbs.  
This study has some limitations. ZDF rats do not completely 
represent humans with T2DM, because the development of 
overt diabetes in ZDF rats is genetically programmed, and their 
disease progression is rapid. That might partly explain why PIB 
animals failed to maintain the initially improved GT constantly. 
The ZDF rats are not better surrogates for the non-obese 
T2DM subjects compared to the Goto-Kakizaki (GK) diabetic 
rats. However, providing an acceptable range of postoperative 
survival rate using GK rats, which are much more vulnerable, 
still remained as an obstacle. In this study, we tested the effects 
of only Roux-en-Y type reconstruction on beta cells and insulin 
signaling. The next step, defining the effects of gastrojejunal 
anastomosis on GT, beta cells, and insulin signaling is 
warranted to offer an additional option as a reconstruction.  
In conclusion, the PIB procedure prevented the further 
decline in plasma insulin levels in the progressive diabetic 
animal model, which may be attributable to the preservation 
of the morphological compensation of the pancreatic islets 
and beta cells to insulin resistance. This procedure also 
facilitated insulin signaling in the peripheral target tissues of 
ZDF rats. The PIB procedure could be considered as a possible 
reconstruction strategy for diabetic gastric cancer patients. 
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